Recent Highlights
All Stories for Whistleblower Complaint
Infosys row: National Financial Reporting Authority to look into alleged accounting irregularities at IT-company
• 5 years agoThe government has asked the National Financial Reporting Authority (NFRA) to look into alleged accounting irregularities at Infosys in the wake of whistleblower complaints, a senior official said on Thursday
Infosys row: When racism, sexism raises head in corporate boards, it is time SEBI intervenes
Jayant Thakur • 5 years agoThe Infosys case, irrespective of what its actual and final findings are, should be a good eye-opener for SEBI
Infosys headed for more trouble; SEBI may seek clarification on whistleblower's complaint, says report
Fp Staff • 5 years agoThe Securities and Exchange Board of India (SEBI) may seek clarification from Infosys' management on charges level levelled by the whistle-blower
Infosys accounting probe: Case may be overblown, but it's an opportunity to fix corporate governance, whistleblower norms
Narayanan Madhavan • 5 years agoInfosys is considered as a bellwether not just for India's emergence as a strong economy in a globalised era in a pioneering export sector, but also for corporate governance and disclosures wore on the sleeves by its iconic founder, NR Narayana Murthy.
PMC Bank saw massive cash withdrawals before RBI clamp down; some large depositors got whiff of whistleblower complaint: Report
• 5 years agoThe whistleblower report has detailed the massive misreporting of NPAs by PMC Bank, primarily because of its huge exposure to crippled developer HDIL that owes around Rs 6,500 crore to the bank
Sun Pharma shares pledged to raise fund for Suraksha; realty firm uses same method thrice in past two years for money
Fp Staff • 6 years agoShanghvi Finance, which is a major shareholder in Sun Pharma, pledged a portion of its stake in India’s largest drugmaker to facilitate Suraksha Realty for raising Rs 100 crore through commercial paper.
Sun Pharma shares drop 3% as SEBI examines whistleblower complaint against the company
• 6 years agoShares of Sun Pharmaceutical fell over 3 percent on Thursday, a day after markets regulator SEBI said it is examining the whistleblower complaint against the company.
Infosys denies US SEC probe, says has sufficient time to file key documents
• 7 years agoThe BSE filing by Infosys comes in the wake of reports that an anonymous whistleblower has flagged concerns over the firm not filing with the US market regulator the stipulated Form 20F, a key document outlining the financials and key risks to the company, generally filed between May and June